In memory of a legendary athlete: measured success in diabetic nephropathy.

Lewis J, Lewis EJ
Semin Nephrol. 2001 21 (2): 124-32

PMID: 11245775 · DOI:10.1053/snep.2001.21211

Historically diabetic nephropathy has been a devastating complication of both type I and type II diabetes. The past 2 decades have seen enormous conceptual advances in understanding the pathogenesis of diabetic nephropathy. The genetic determinants of diabetic renal disease have also been elucidated as well as biochemical events and cytokine interactions. Most importantly, key clinical trials have identified therapeutic interventions which can slow or halt the progression of diabetic nephropathy, specifically the therapeutic use of angiotensin-converting enzyme inhibition and intensive blood sugar control. Multiple treatment modalities for patients once they reach end-stage renal disease are also available and great strides have been improving outcomes in these areas as well.

Copyright 2001 by W.B. Saunders Company

MeSH Terms (6)

Baseball Diabetic Nephropathies Famous Persons History, 20th Century Humans Male

Connections (1)

This publication is referenced by other Labnodes entities: